COEPW vs. ATNFW, SXTPW, DRTSW, WENAW, APLMW, BCTXW, CDIOW, CTCXW, CELUW, and CEROW
Should you be buying Coeptis Therapeutics stock or one of its competitors? The main competitors of Coeptis Therapeutics include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Anew Medical (WENAW), Apollomics (APLMW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Carmell (CTCXW), Celularity (CELUW), and CERo Therapeutics (CEROW). These companies are all part of the "biotechnology" industry.
Coeptis Therapeutics vs.
180 Life Sciences (NASDAQ:ATNFW) and Coeptis Therapeutics (NASDAQ:COEPW) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, earnings, analyst recommendations, community ranking, risk, media sentiment, profitability, valuation and institutional ownership.
180 Life Sciences and Coeptis Therapeutics both received 0 outperform votes by MarketBeat users.
In the previous week, Coeptis Therapeutics had 1 more articles in the media than 180 Life Sciences. MarketBeat recorded 2 mentions for Coeptis Therapeutics and 1 mentions for 180 Life Sciences. 180 Life Sciences' average media sentiment score of 1.89 beat Coeptis Therapeutics' score of 0.93 indicating that 180 Life Sciences is being referred to more favorably in the media.
Summary
180 Life Sciences and Coeptis Therapeutics tied by winning 1 of the 2 factors compared between the two stocks.
Get Coeptis Therapeutics News Delivered to You Automatically
Sign up to receive the latest news and ratings for COEPW and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
COEPW vs. The Competition
Coeptis Therapeutics Competitors List
Related Companies and Tools
This page (NASDAQ:COEPW) was last updated on 4/30/2025 by MarketBeat.com Staff
Buy COEPW Stock Free COEPW Stock Alerts